Antiplatelet agents for chronic kidney disease.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 35224730)

Published in Cochrane Database Syst Rev on February 28, 2022

Authors

Patrizia Natale¹^,2^,3, Suetonia C Palmer⁴, Valeria M Saglimbene¹^,2, Marinella Ruospo¹^,2, Mona Razavian⁵, Jonathan C Craig²^,6, Meg J Jardine⁷, Angela C Webster²^,8, Giovanni Fm Strippoli¹^,2^,6

Author Affiliations

1: Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
2: Sydney School of Public Health, The University of Sydney, Sydney, Australia.
3: Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
4: Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
5: Renal and Metabolic Division, The George Institute for Global Health, Newtown, Australia.
6: Cochrane Kidney and Transplant, Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, Australia.
7: NHMRC Clinical Trials Centre, Camperdown, Australia.
8: Centre for Transplant and Renal Research, Westmead Millennium Institute, The University of Sydney at Westmead, Westmead, Australia.

Associated clinical trials:

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome (PLATO) | NCT00391872

Secondary Prevention of Small Subcortical Strokes Trial (SPS3) | NCT00059306

A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention | NCT00097591

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) | NCT00050817

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737) | NCT00526474

A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects (TRILOGY ACS) | NCT00699998

Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria (Steno-2) | NCT00320008

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736) | NCT00527943

A Phase III Study of Apixaban in Patients With Atrial Fibrillation (AVERROES) | NCT00496769

PeriOperative ISchemic Evaluation-2 Trial (POISE-2) | NCT01082874

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) | NCT01225562

Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events (CHANCE) | NCT00979589

Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention (PRODIGY) | NCT00611286

Vascular Access Clinical Trials Data Coordinating Center | NCT00067119

EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED) | NCT00089895

Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial | NCT00110448

Prospective Randomized Study Comparing Renal Artery Stenting (RESIST)With/Without Distal Protection | NCT00234585

The Efficacy of CILostazol ON Ischemic Complications After DES Implantation (CILON-T) | NCT00776828

TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis) | NCT01090037

Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease (CKD) | NCT01328470

Stenting of Renal Artery Stenosis in Coronary Artery Disease Study (RASCAD) | NCT01173666

Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy | NCT01743014

Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study (SERENADE) | NCT02294643

The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease | NCT01165567

Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study) | NCT01869881

Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients | NCT01709994

COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS (OPT-CKD) | NCT02578537

Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients (APROVE-CKD) | NCT02459288

Ticagrelor and Anti-inflammatory Effects | NCT02406911

Genotype and Platelet Reactivity in Patients on Hemodialysis | NCT02394145

ONSET and OFFSET of Ticagrelor in ESRD | NCT02163954

Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects | NCT02022748

A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy | NCT01252056

Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients | NCT01198379

Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis | NCT01155765

Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor | NCT03039205

Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD (CPRS-CKD) | NCT03150667

Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis (FISTULA) | NCT03289520

TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome. (TROUPER) | NCT03357874

Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction (ALTIC-2) | NCT03387826

Chronic Kidney Disease (CKD) Platelet Study | NCT03649711

Aspirin to Target Arterial Events in Chronic Kidney Disease (ATTACK) | NCT03796156

Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes (LEDA) | NCT02895113

A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction (ALTIC) | NCT02663713

Articles by these authors ⇆

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis. Lancet (2015) 3.36

Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials. Am J Kidney Dis (2014) 2.78

A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research. Nephrol Dial Transplant (2015) 1.45

Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies. Am J Kidney Dis (2014) 1.19

Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med (2013) 1.01

Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis. JAMA (2016) 0.96

Patient and caregiver values, beliefs and experiences when considering home dialysis as a treatment option: a semi-structured interview study. Nephrol Dial Transplant (2015) 0.84

Patient satisfaction with in-centre haemodialysis care: an international survey. BMJ Open (2014) 0.84

Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study. BMJ Open (2015) 0.80

COGNITIVE-HD study: protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis. BMJ Open (2015) 0.78

Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials. Am J Kidney Dis (2016) 0.78

Preemptive Correction of Arteriovenous Access Stenosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Kidney Dis (2016) 0.76

Healthy Dietary Patterns and Risk of Mortality and ESRD in CKD: A Meta-Analysis of Cohort Studies. Clin J Am Soc Nephrol (2016) 0.75

Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis. PLoS One (2017) 0.75

Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial. PLoS One (2017) 0.75

Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials. Am J Kidney Dis (2017) 0.75

A nephrology guide to reading and using systematic reviews of randomized trials. Nephrol Dial Transplant (2014) 0.75

Patterns of oral disease in adults with chronic kidney disease treated with hemodialysis. Nephrol Dial Transplant (2015) 0.75

Associations of Cognitive Function and Education Level With All-Cause Mortality in Adults on Hemodialysis: Findings From the COGNITIVE-HD Study. Am J Kidney Dis (2019) 0.75

Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study. Nephrol Dial Transplant (2017) 0.75